CJC1295 / without DAC + IPA

Stimulates Growth

$220.00

Product Overview

CP10 is a catalog identifier often used by research-peptide suppliers to designate a 10 mg vial containing a blend of two peptides:

  1. CJC-1295 without DAC — a short-acting GHRH analog

  2. Ipamorelin — a ghrelin mimetic / GHRP-type peptide

This combination is popular in research investigating growth-hormone release pathways, pituitary signaling, and synergistic GHRH/GHRP interactions.

The product is typically supplied in a lyophilized powder format for controlled research settings.

 Scientific Background

1. CJC-1295 (without DAC)

A modified fragment of GHRH with:

  • increased stability vs endogenous GHRH

  • selective activation of GHRH receptors

  • shorter half-life than the DAC version, making it useful for pulse-pattern studies

Researchers use this molecule to model physiological GH-releasing signals.

2. Ipamorelin

A selective ghrelin receptor (GHSR) agonist, known for:

  • high specificity for GH release

  • minimal activity on cortisol, prolactin, or aldosterone (in research models)

  • strong synergy with GHRH analogs

Together, CJC-1295 w/o DAC and Ipamorelin allow examination of dual-pathway GH modulation — something not possible using either peptide alone.